Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Toxicity of molecularly targeted antiangiogenic agents: Non-cardiovascular effects


Toni K Choueiri, MD

Director, The Lank Center for Genitourinary Oncology

Dana-Farber Cancer Institute and Brigham and Women's Hospital

Associate Professor of Medicine

Harvard Medical School

Guru Sonpavde, MD

Associate Professor of Medicine

Director, Urologic Medical Oncology

UAB Comprehensive Cancer Center

Section Editors

Michael B Atkins, MD

Section Editor — Malignant Melanoma and Other Cutaneous Neoplasms; Cancer of the Kidney

Deputy Director

Georgetown Lombardi Comprehensive Cancer Center

Richard M Goldberg, MD

Section Editor — Gastrointestinal Cancer

Director of the West Virginia University Cancer Institute and the Mary Babb Randolph Cancer Center

Professor of Medicine

Laurence S. & Jean J. DeLynn Chair of Oncology

Richard A Larson, MD

Editor-in-Chief — Hematology

Section Editor — Leukemia

Professor of Medicine

University of Chicago Pritzker School of Medicine

Deputy Editors

Diane MF Savarese, MD

Senior Deputy Editor — UpToDate

Deputy Editor — Oncology and Palliative Care

Clinical Instructor of Medicine

Harvard Medical School

Jennifer S Tirnauer, MD

Deputy Editor — Hematology

Peer Reviewer

Reviewers are not identified on topic reviews to preserve anonymity